Ketina Hirma Tchio-Nighie
Biographic Data
| ID | 7042426 |
|---|---|
| NAME | Ketina Hirma Tchio-Nighie |
| GIVEN NAMES | Ketina Hirma |
| FAMILY NAME | Tchio-Nighie |
| SIGNATURE | TCHIO-NIGHIE K H |
| AFFILIATIONS | Université de Dschang |
| ORCID | 0000-0003-4887-8931 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Serological responses to killed oral cholera vaccine (OCV) when given 4 years after initial receipt of OCV in Cameroon
Oral cholera vaccination (OCV) is one of strategies to help control cholera with two doses recommended as initial vaccination and booster doses recommended 3–5 years later to prevent future outbreaks. There is no actual recommendation on the number of doses required during booster vaccination. An OCV campaign conducted in Mogode-Cameroon provided an opportunity to determine if revaccination four years after would induce a booster response. 350 pe…
Chronic diseases and mortality among hospitalised Covid-19 patients at Bafoussam Regional Hospital in the West region of Cameroon
Reducing mortality among COVID-19 cases is a major challenge for most health systems worldwide. Estimating the risk of preexisting comorbidities on COVID-19 mortality may promote the importance of targeting at-risk populations to improve survival through primary and secondary prevention. This study was conducted to explore the contribution of exposure to some chronic diseases on the mortality of COVID-19. This was a case control study. The data w…
An innovative approach in monitoring oral cholera vaccination campaign
It is feasible to plan and implement coverage survey after first round OCV campaign and use its results for the better planning of the second round. For the present study, this is associated to the improvement of OCV coverage in the second-round vaccination. If this is persistent in other contexts, it may apply to improve coverage of any health campaign that is organized in more than one round
No prominent works on this page.
An innovative approach in monitoring oral cholera vaccination campaign
It is feasible to plan and implement coverage survey after first round OCV campaign and use its results for the better planning of the second round. For the present study, this is associated to the improvement of OCV coverage in the second-round vaccination. If this is persistent in other contexts, it may apply to improve coverage of any health campaign that is organized in more than one round
Chronic diseases and mortality among hospitalised Covid-19 patients at Bafoussam Regional Hospital in the West region of Cameroon
Reducing mortality among COVID-19 cases is a major challenge for most health systems worldwide. Estimating the risk of preexisting comorbidities on COVID-19 mortality may promote the importance of targeting at-risk populations to improve survival through primary and secondary prevention. This study was conducted to explore the contribution of exposure to some chronic diseases on the mortality of COVID-19. This was a case control study. The data w…
Serological responses to killed oral cholera vaccine (OCV) when given 4 years after initial receipt of OCV in Cameroon
Oral cholera vaccination (OCV) is one of strategies to help control cholera with two doses recommended as initial vaccination and booster doses recommended 3–5 years later to prevent future outbreaks. There is no actual recommendation on the number of doses required during booster vaccination. An OCV campaign conducted in Mogode-Cameroon provided an opportunity to determine if revaccination four years after would induce a booster response. 350 pe…
Cholera vaccine (2 works) · Medicine (2 works) · Vaccination (2 works) · Vibrio bacteria research studies (2 works) · Bacillus and Francisella bacterial research (1 works) · Biostatistics (1 works) · Booster (rocketry) (1 works) · Booster dose (1 works) · Cholera (1 works) · Christian ministry (1 works)